Frick lab’s Estrigenix collaboration profiled on WTMJ-TV

Dr. Frick’s collaboration with colleagues at Marquette University and Concordia University Wisconsin to develop new ERbeta-specific drugs for relieving menopausal symptoms and reducing dementia risk was profiled on TMJ4 News and in a more detailed interview on Facebook. The collaboration has spawned a new company, Estrigenix Therapeutics, Inc., whose mission is to license these compounds for pharmaceutical development.  Dr. Frick is a co-founder and the Chief Scientific Officer of Estrigenix.

Sarah Philippi to present her research on Capitol Hill!

Senior undergraduate Sarah Philippi was selected to present her Alzheimer’s Association-funded research at the 2019 Posters on the Hill event in Washington, DC.  Sarah was the only student selected from the state of Wisconsin!  She will present her work on Capitol Hill and discuss her research with legislators from Wisconsin.  Congratulations to Sarah on being selected to represent not only UWM, but the entire state of Wisconsin!